Log In
Print
BCIQ
Print
Print this Print this
 

Biophage-PR (AmpliPhage-001)

  Manage Alerts
Collapse Summary General Information
Company AmpliPhi Biosciences Corp.
DescriptionLytic bacteriophages against Pseudomonas aeruginosa
Molecular Target
Mechanism of Action 
Therapeutic ModalityGene therapy
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat Pseudomonas aeruginosa infection associated with cystic fibrosis (CF)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today